secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001437749-23-019831
Event type: leadership
Sentiment:  negative
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chief Business Officer Ahmed Mousa resigns to become CEO of Vicore Pharma
-------------------------------------------------------------------------

- Ahmed Mousa to resign as SVP, Chief Business Officer, General Counsel & Corporate Secretary effective September 11, 2023.
- Resignation to become CEO of Vicore Pharma Holding AB; no disagreement with Pieris on any matter.
- CEO Stephen Yoder will oversee corporate and business development following Mousa's departure.
- Mousa expected to serve as strategic advisor for a transition period subject to mutual terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/0001437749-23-019831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774923019831/pirs20230705c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-019831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer